• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Full Federal Reserve policy statement Sept 22, 2021

September 22, 2021 by David Barret Leave a Comment

September 22, 2021

(Reuters) – Following is the full statement issued by the Federal Open Market Committee on Sept. 22, 2021:

The Federal Reserve is committed to using its full range of tools to support the U.S. economy in this challenging time, thereby promoting its maximum employment and price stability goals.

With progress on vaccinations and strong policy support, indicators of economic activity and employment have continued to strengthen. The sectors most adversely affected by the pandemic have improved in recent months, but the rise in COVID-19 cases has slowed their recovery. Inflation is elevated, largely reflecting transitory factors. Overall financial conditions remain accommodative, in part reflecting policy measures to support the economy and the flow of credit to U.S. households and businesses.

The path of the economy continues to depend on the course of the virus. Progress in vaccinations will likely continue to reduce the effects of the public health crisis on the economy, but risks to the economic outlook remain.

The Committee seeks to achieve maximum employment and inflation at the rate of 2 percent over the longer run. With inflation having run persistently below this longer-run goal, the Committee will aim to achieve inflation moderately above 2 percent for some time so that inflation averages 2 percent over time and longer‑term inflation expectations remain well anchored at 2 percent. The Committee expects to maintain an accommodative stance of monetary policy until these outcomes are achieved. The Committee decided to keep the target range for the federal funds rate at 0 to 1/4 percent and expects it will be appropriate to maintain this target range until labor market conditions have reached levels consistent with the Committee’s assessments of maximum employment and inflation has risen to 2 percent and is on track to moderately exceed 2 percent for some time. Last December, the Committee indicated that it would continue to increase its holdings of Treasury securities by at least $80 billion per month and of agency mortgage‑backed securities by at least $40 billion per month until substantial further progress has been made toward its maximum employment and price stability goals. Since then, the economy has made progress toward these goals. If progress continues broadly as expected, the Committee judges that a moderation in the pace of asset purchases may soon be warranted. These asset purchases help foster smooth market functioning and accommodative financial conditions, thereby supporting the flow of credit to households and businesses.

In assessing the appropriate stance of monetary policy, the Committee will continue to monitor the implications of incoming information for the economic outlook. The Committee would be prepared to adjust the stance of monetary policy as appropriate if risks emerge that could impede the attainment of the Committee’s goals. The Committee’s assessments will take into account a wide range of information, including readings on public health, labor market conditions, inflation pressures and inflation expectations, and financial and international developments.

Voting for the monetary policy action were Jerome H. Powell, Chair; John C. Williams, Vice Chair; Thomas I. Barkin; Raphael W. Bostic; Michelle W. Bowman; Lael Brainard; Richard H. Clarida; Mary C. Daly; Charles L. Evans; Randal K. Quarles; and Christopher J. Waller.

Source Link Full Federal Reserve policy statement Sept 22, 2021

David Barret
David Barret

Related posts:

  1. India, Australia eye closer security ties as 9/11 anniversary marked
  2. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  3. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn
  4. Soccer-Spurs upset Man City in controversial Women’s Super League win

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Perfect Sphere Of Plasma Discovered In Space Is A Conundrum Waiting To Be Solved
  • What Happened In The First Human-To-Human Heart Transplant?
  • Having An “Aha!” Moment When Solving A Puzzle “Almost Doubles” Your Memory
  • What’s Your Chronotype, And Why Should You Care?
  • Never-Seen-Before Bacterium Discovered On China’s Tiangong Space Station
  • Whale Calves Are Born On “Humpback Highway”, Changing What We Knew About Migration
  • USA’s New Most Powerful Laser Comparable To 100 Times The Global Electricity Output
  • There’s Only One Bird Species That Can Truly Fly Backwards
  • Tomb Of Roman Priestess Of The Goddess Ceres Found At Pompeii
  • Science News, Articles | IFLScience
  • The Longest Predatory Dinosaur Known To Science Was Probably A Great Dad, Too
  • A Giant White Light Beam Cuts Through The Skies Over US Amid Aurora Storm
  • Western Diamondback Rattlesnake Found With More Of A “Leopard Spot” Pattern Than Diamonds
  • 140,000-Year-Old Homo Erectus Remains Discovered Alongside Other Animals In Drowned Sundaland
  • Being Sane In Insane Places: The Rosenhan Experiment Changed Psychiatry. But Was It All It Seemed?
  • Stealing Baby Howler Monkeys Is Suddenly All The Rage Among Capuchins On Jicarón Island
  • Former US President Joe Biden Has “Grade Group 5” Prostate Cancer: Here’s What That Means
  • “Self-Boosting” Vaccines Trap Doses In Microparticles For Later Release Inside The Body
  • Supermassive Black Hole’s Storm Throws Gas “Bullets” At 30 Percent Of The Speed Of Light
  • Please Don’t Shave Off Your Eyelashes, People – You Need Them
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version